MDR - G7 Neutral and G7 Freedom Constrained Neutral Acetabular Liners
NCT: NCT04093739 · WITHDRAWN
Brief Summary
The objective of this consecutive series PMCF study is to collect data confirming safety, performance and clinical benefits of the G7 Freedom Constrained Liners when used for primary and revision total hip arthroplasty (implants and instrumentation) at 5 years follow-up. Since G7 Acetabular Cup System has only been on the market since 2015, a prospective follow-up will be necessary to obtain data for the 5 year post-surgery time-point for each patient.
Frequently Asked Questions
What is MDR - G7 Neutral and G7 Freedom Constrained Neutral Acetabular Liners?
MDR - G7 Neutral and G7 Freedom Constrained Neutral Acetabular Liners is a clinical trial registered under NCT04093739. Current status: WITHDRAWN.
What is the status of NCT04093739?
The current status of NCT04093739 (MDR - G7 Neutral and G7 Freedom Constrained Neutral Acetabular Liners) is: WITHDRAWN.
When did MDR - G7 Neutral and G7 Freedom Constrained Neutral Acetabular Liners start?
MDR - G7 Neutral and G7 Freedom Constrained Neutral Acetabular Liners started on 2022-04-01.
Related Devices
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.